Richard Hermann

Statistics

Publications

Citations

217

H-Index

Active since

2012

Affiliations

AstraZeneca (United States)(Current)

KU Leuven

Sanofi (United States)

Erasmus University Rotterdam

Uppsala University

Richard Hermann is an author at AstraZeneca (United States) specializing in patient preferences, semi-structured interviews, and eliciting patient preferences.

ORCID

Publications per year

2012–2022

Publications

An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?

Chiara Whichello, Karin Schölin Bywall, Jonathan Mauer et al. · Health Policy · 2020 · 40 citations · Full text

Business, Health Information Management, Clinical Decision Support +16

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA

Rosanne Janssens, Selena Russo, Eline van Overbeeke et al. · Patient · 2019 · 38 citations · Full text

Public Affairs, Health Care Management, Health Policy +17

MAJIC: A Phase III Trial of Acalabrutinib + Venetoclax versus Venetoclax + Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Christine E. Ryan, Matthew S. Davids, Richard Hermann et al. · Future Oncology · 2022 · 35 citations · Full text

Medicine, Hematology, Oncology +17

Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation

Arthur J. Labovitz, David Z. Rose, Michael G. Fradley et al. · Stroke · 2021 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Application of the Benefit-Risk Action Team (BRAT) Framework in Pharmaceutical R&D: Results From a Pilot Program

Rebecca Noel, Richard Hermann, Bennett Levitan et al. · Drug Information Journal · 2012 · 21 citations

Pharmacy, Pharmaceutical Policy, Risk Management +15

1–5 of 8